PreComb Therapeutics AG
Formerly, Executive Director and Head of the Production & Processes department of ESBATech, a Novartis company. He headed the technical development unit, responsible for process development and clinical supply for multiple global clinical studies. As a co-founder and member of the board, he successfully led the aquisition of Insilico Biotechnology AG by Yokogawa Electric corporation. Peter holds a PhD in Biotechnology from the ETH Zürich.
PreComb Therapeutics AG
PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers.